Skip to main content

News & Articles

UTHealth Research

November 10, 2022
Written By: Roman Petrowski, McGovern Medical School | Updated: November 10, 2022
A five-year, $3.3 million grant to research receptor-targeted fluorescence-guided surgery in pancreatic neuroendocrine tumors has been awarded to UTHealth Houston researcher Ali Azhdarinia, PhD, by the National Institutes of Health (NIH).
November 10, 2022
Written By: Darla Brown, McGovern Medical School | Updated: November 10, 2022
Research from McGovern Medical School’s Department of Pediatrics at UTHealth Houston has yielded a noninvasive diagnostic tool for an increasingly prevalent chronic immune system disease, eosinophilic esophagitis (EoE).
October 24, 2022
Written By: Roman Petrowski, McGovern Medical School | Updated: October 24, 2022
Recent research from the labs of Danielle Garsin, PhD, and Michael Lorenz, PhD, professors in the Department of Microbiology and Molecular Genetics with McGovern Medical School at UTHealth Houston, which identified a novel potential therapeutic against fungal infections, has been published in Nature Communications.
October 10, 2022
Written By: Halle Jones | Updated: October 10, 2022
Researchers at UTHealth Houston saw an increase in pediatric firearm-related injuries during the COVID-19 pandemic, despite also seeing a decrease in total pediatric emergency department (ED) visits over the same period, according to a poster presented at the 2022 American Academy of Pediatrics National Conference & Exhibition in Anaheim, California.
October 5, 2022
Written By: Halle Jones | Updated: October 5, 2022
Using a combination of biomarkers and mood assessments, researchers will study how pregnant women who are experiencing depression respond to different antidepressants in a clinical trial funded by a grant from the National Institutes of Health to UTHealth Houston.  Depression affects approximately 12% of pregnant women, according to the Centers for Disease Control and Prevention.